# ZOLADEX

NDC: 70720-951
Generic name: goserelin
Labeler / Manufacturer: TerSera Therapeutics LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: IMPLANT
Routes: SUBCUTANEOUS
Marketing started: 20180126

FDA application: NDA020578

## Active ingredients

- GOSERELIN ACETATE: 10.8 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"70720-951"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=70720-951
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e4cb3c20-2738-400a-b522-3f36f71fe6c5